  Copy number alterations (CNAs) are thought to account for 85% of the
variation in gene expression observed among breast tumours. The expression of
cis-associated genes is impacted by CNAs occurring at proximal loci of these
genes, whereas the expression of trans-associated genes is impacted by CNAs
occurring at distal loci. While a majority of these CNA-driven genes
responsible for breast tumourigenesis are cis-associated, trans-associated
genes are thought to further abet the development of cancer and influence
disease outcomes in patients. Here we present a network-based approach that
integrates copy-number and expression profiles to identify putative cis- and
trans-associated genes in breast cancer pathogenesis. We validate these cis-
and trans-associated genes by employing them to subtype a large cohort of
breast tumours obtained from the METABRIC consortium, and demonstrate that
these genes accurately reconstruct the ten subtypes of breast cancer. We
observe that individual breast cancer subtypes are driven by distinct sets of
cis- and trans-associated genes. Among the cis-associated genes, we recover
several known drivers of breast cancer (e.g. CCND1, ERRB2, MDM2 and ZNF703) and
some novel putative drivers (e.g. BRF2 and SF3B3). siRNA-mediated knockdown of
BRF2 across a panel of breast cancer cell lines showed significant reduction
specifically in cell proliferation in HER2+ lines, thereby indicating that BRF2
could be a context-dependent oncogene and potentially targetable in these
lines. Among the trans-associated genes, we identify modules of immune-response
(CD2, CD19, CD38 and CD79B), mitotic/cell-cycle kinases (e.g. AURKB, MELK, PLK1
and TTK), and DNA-damage response genes (e.g. RFC4 and FEN1).
